Conferences and Meetings on Oncology

In this special program, world leaders in cancer research from Harvard and other internationally recognized institutes share their insights, and participants learn the new fundamentals of a wide spectrum of cancer science. You will gain the skills necessary to envision, design, and lead cutting-edge cancer research projects that can contribute to the diagnosis, prevention, and treatment of cancer. This year-long program is designed to help participants make high-impact contributions that lead to better cancer outcomes.

Email: CR@hms.harvard.edu

Harvard, mentor, cancer research, hybrid, workshops, webinars, comprehensive curriculum

3rd International Cancer Conference and Expo welcomes you as our guest to the City of Baltimore, USA during June 05-07, 2019. This 3rd International Cancer Conference and Expo aims in Driving Innovative Cancer Science Towards Precision Medicine. iCancer USA includes nearly every permutation of knowledge, innovation, technology and networking; and has an objective of creating an international forum for academicians, practitioners and business professionals to discuss the soundest issues related to Cancer, Biotech and Health Care.

john stewart;     Phone: [16193784793];     Email: john@icancerconference.com

Cancer genes, Chemotherapy, Hypoxia, Sarcomas, Lung Cancer, Oral Cancer, Bladder Cancer, Skin Cancer, Hematology, Medical Imaging, Prognosis, Radiotherapy, clinical trials, Epidemiology, Breast cancer, Cancer, Geneticist, Immune system, Pathologist, Prosthesis, Thermography, X-ray, Biopsy, Cervical Cancer, Bone Cancer, Brain Tumors, Kidney Tumors, Urethral Cancer, Thyroid Cancer, Throat Cancer, T-Cell Lymphoma, Soft Tissue Sarcoma, Prostate Cancer, Ovarian Cancer, Leukemia, Kidney Cancer, Carcinoid Tumor, Cancer Stem Cells, Apoptosis, CV Imaging, Cancer Stem Cells, Gastric cancer, Cancer Clinical Trials, Oncology, Chemotherapy

Die interdisziplinäre Fortbildungsveranstaltung wird fallbasiert aufgebaut: Von der klinischen Fragestellung zur Schlüsselempfehlung der Leitlinien

Phone: [03643 2468-129];     Email: juliane.truskowski@ng-akademie.de

Plattenepithelkarzinom, Haut, Onkologie, Dermatologie, Dermatohistologie, Fortbildungsveranstaltung, Berlin

Dermatology,    Continuing Medical Education (CME)

Sciinov invites all the participants from all over the world to attend "Global Conference on Oncology and Radiology" going to be held in Rome, Italy during 27-28, May 2019. GCOR-Rome includes prompt keynote presentations, Oral talks, Poster presentations, Workshops, Symposiums and Exhibitions.

Phone: [+1-732-526-1166];     Email: oncology@sciinovgroup.com

Die interdisziplinäre Fortbildungsveranstaltung wird fallbasiert aufgebaut: Von der klinischen Fragestellung zur Schlüsselempfehlung der Leitlinien

Phone: [03643 2468-129];     Email: juliane.truskowski@ng-akademie.de

Onkologie, Palliativmedizin, Fortbildungsveranstaltung, Berlin

Fusion Conferences

New diagnostic technologies and therapeutic approaches are being developed and implemented which will transform patient management in the near future. As with the previous two meetings, this conference will include academic scientists and industry.

Pharmacology and Drug Development,    Medicine (in general)

Phone: [215-664-5492];     Email: cancer@scitechconferences.org

3rd International Cancer Conference and Expo welcomes you as our guest to the City of Baltimore, USA during June 05-07, 2019. iCancer USA 2019 aims in "Driving Innovative Cancer Science Towards Precision Medicine". This conference provides a forum for exchange of ideas and authoritative views by eminent personalities in this exciting field, by bringing together Cancer Science, Drug Development, Nanotechnology in Cancer Treatment, Robotic Surgery, Therapies, Oncology, Clinical trials, Cancer imaging, Medical radiation, Cancer detection, Control and Prevention research professionals; Academicians, Doctors, Study sponsors, Related Associations & Societies; Executives from Bio-Engineering, Diagnosis Tools, Medical devices and Pharmaceutical industries around the globe. iCancer USA 2019 offers unparalleled business, research opportunities and access to new markets in Cancer and Health Care industry. Be on the cutting edge of new and often yet-unreleased information and discover an area that piques your interest. Join us and witness the booming industry by participating at iCancer USA 2019 and give your career and business access to new opportunities from throughout the world.

Phone: [16193784793];     Email: john@icancerconference.com

Cancer genes, Chemotherapy, Hypoxia, Sarcomas, Lung Cancer, Oral Cancer, Bladder Cancer, Skin Cancer, Hematology, Medical Imaging, Prognosis, Radiotherapy, clinical trials, Epidemiology, Breast cancer, Cancer, Geneticist, Immune system, Pathologist, Prosthesis, Thermography, X-ray, Biopsy, Cervical Cancer, Bone Cancer, Brain Tumors, Kidney Tumors, Urethral Cancer, Thyroid Cancer, Throat Cancer, T-Cell Lymphoma, Soft Tissue Sarcoma, Prostate Cancer, Ovarian Cancer, Leukemia, Kidney Cancer, Carcinoid Tumor, Cancer Stem Cells, Apoptosis, CV Imaging, Cancer Stem Cells, Gastric cancer, Cancer Clinical Trials, Oncology, Chemotherapy

Stem-cell Research & Therapy,    Radiology: Nuclear Magnetic Resonance Imaging

UKIO is the permanent amalgamation of two well-known conferences – the UK Radiological Congress (UKRC) and the UK Radiation Oncology Conference (UKRO). 2019 will be the first year that this unified event will run as UKIO. This annual event consists of a three-day multidisciplinary scientific congress and technical exhibition, is aimed at all those involved in the field of radiological science and radiation oncology and attracts over 2,000 attendees. The 2019 theme is Personalise & Humanise. The scientific programme, that promises to be both innovative and varied, will create a true multidisciplinary congress, covering the widest range of topics.

Phone: [020 3725 5840];     Email: ukio@profileproductions.co.uk

radiology, radiography, oncology, radiotherapy, imaging, medical imaging, medical physics, physics

58th Annual Conference of The Particle Therapy Co-Operative Group - the premier meeting in the field of particle therapy, showcasing cutting edge science, NHS oncology and clinical practice in action.

PTCOG58 Secretariat;     Phone: [+41 22 908 0488];     Email: tpinski@kenes.com

the premier meeting in the field of particle therapy, showcasing cutting edge science, NHS oncology and clinical practice in action.

Liebe Kolleginnen und Kollegen, vom 31. Mai bis zum 4. Juni 2019 findet das jährliche Meeting der American Society of Clinical Oncology (ASCO) statt. Studienergebnisse, die unsere Standards in der Onkologie beeinflussen, werden in Chicago vorgestellt und diskutiert. Mit unserem Leipziger Post-Chicago Compact bieten wir zeitnah und effizient eine Plattform für Informationen und Diskussion über die relevantesten Entwicklungen in der Klinischen Onkologie. Wir laden Sie herzlich ein, an diesem Austausch teilzunehmen. Für ein angenehmes Ambiente und Verpflegung ist in der Kongresshalle am Zoo Leipzig gesorgt. Wir hoffen Ihr Interesse für vielfältige Neuigkeiten und Ihre Diskussionsfreude mit diesem Programm geweckt zu haben.

Phone: [(03 41) 97 - 1 25 60];     Email: Nadine.Orthofer@uniklinik-leipzig.de

Onkologie, Klinische Onkologie, Post Chicago Compact

Cancer Genomics 2019 is the fourth EACR conference on this topic, and it is now widely recognised as the premier European conference dedicated to cancer genomics. In 2019 it will again cover the latest exciting developments: convergence (modelling, artificial intelligence and big data), single cell analysis of cancers, cancer immune genomics, and clinical applications of genomics.

Email: l.strachan@nottingham.ac.uk

genomics, metastasis, immunology, cancer, oncology, Transcriptome, single cell RNA-seq, epigenetics, genome regulation, bioinformatics, epigenomics, genomics

Physicians and allied health professionals will improve their understanding of contemporary, multimodality approaches, minimally-invasive surgery of lung cancer, early stage advanced tumours and rare thoracic malignancies. The course will help participants to appreciate the importance of a multidisciplinary approach to diagnosing and treating thoracic malignancies and understand roles of thoracic surgery in the era of targeted therapy and immunotherapy. This conference is open to GPs, chest physicians, thoracic oncologists, thoracic surgeons, dietitians and allied health professionals who care for patients with thoracic oncologic diseases including lung cancer, mesothelioma, and thymic malignancies.

Education and Events Team;     Phone: [+44 (0)20 7188 1622];     Email: events@gstt.nhs.uk

thoracic oncology, thoracic surgery, thoracic oncologic diseases, lung cancer, mesothelioma, thymic malignancies

The 7th Antibody Industrial Symposium (AIS2019) will be held on June 24-25, 2019 in Tours, France. This year edition will focus on Harnessing the Immune System with mAbs, a major topic chosen by the AIS Scientific Advisory Board constituted by Pierre Fabre, Servier, IRCM, MabDesign, Sanofi, OSE Immunotherapeutics, LFB, CEPR, IGMM, LabEx MabImprove, and Tours University. Join more than 300 experts expected for this new edition, working in the field of mAbs and related services and technologies.

Email: ana-sofia.antunes@mabdesign.fr

The topics addressed during this congress are: - Harnessing the Immune system with Immunomodulatory therapeutic Antibodies; - Immunomodulation via cell membrane antigens; - Immunomodulation with therapeutic antibodies – new strategies & technologies; - Immunomodulation via Soluble Antigens; - Immunomodulation FC – FcyR interactions.

Immunology and allergic diseases,    Translational Medicine, Clinical Trials

Larix international is delighted to invite you to attend the International Conference on ICCB 2019, one of its remarkable conferences, to be held during June 24th-25th, 2019 in Singapore, emphasizing on recent areas of more optimized research techniques in cancer biology, cancer biomarkers than by traditional hit and trial method. This ICCB 2019 conference includes a wide range of keynote presentations, oral talks, poster presentations, symposia, workshops, exhibitions and career development programs. The conference sets the stage for the dissemination and exchange of new developments in diverse, hot fields within cancer biology and anti-cancer therapies, being the platform for inspiration, collaboration and networking for researchers in academia and industry.

Phone: [9739889147];     Email: cancer@larixconferences.com

After the great success of the 1st Cologne Conference on Lung Cancer (CCLC) in April 6-7, 2017, we are again looking forward to an exciting meeting on cutting-edge translational research in lung cancer. So we are very pleased to announce the 2nd Cologne Conference on Lung Cancer from June 26-27, 2019 which will take place again at the Maritim Hotel Cologne. This conference brings together the best international specialists of lung cancer research to discuss the current challenges in diagnostics and therapy with topics like immune checkpoint inhibitors: resistance and combinations, immunotherapy: beyond PD1, news from the kinome, clonal heterogeneity and resistance as well targeted therapy of SCLC. The 2nd Cologne Conference on Lung Cancer has an interactive orientation with a strong focus ondiscussion.

Phone: [+49 3643 2468-147];     Email: lisa.dinter@kukm.de

Lunge, Lungekrebs, Pneumologie, Pulmologie, Beatmungsmedizin

Um den Hämatologen und Onkologen im gesamten deutschsprachigen Raum die aktuellen Neuerungen im diagnostischen und therapeutischen Bereich der Hämatologie und Onkologie kompakt zu vermitteln, wird der Onko 3-Länder-Update Spezial vom 28. - 29. Juni 2019 in München durchgeführt. Dabei informieren ausgewiesene Experten aus Deutschland, Österreich und der Schweiz über die aktuellen Trends der (inter)nationalen klinischen Hämatologie/Onkologie-Therapie und -Forschung. Neben den wichtigsten chemo- und immun-therapeutischen Behandlungen von zahlreichen Organ- und Blutkrebsarten werden im Besonderen die Möglichkeiten und Herausforderungen innovativer diagnostischer Methoden fokussiert und im Plenum diskutiert.

Diese praxisorientierte Fortbildung bietet:

ein umfassendes Update für Onkologen und Hämatologen

ein Kursbuch mit den Power-Point-Präsentationen der Vorträge

Interaktivität mittels Teilnahme an TED-Votings

Forum für medizinische Fortbildung;     Email: info@fomf.de

Onkologie/Hämatologie I, Onkologie/Hämatologie II, Onkologie/Hämatologie III, Onkologie/Hämatologie IV

Medicine (in general),    Hematology

Um den Hämatologen und Onkologen im gesamten deutschsprachigen Raum die aktuellen Neuerungen im diagnostischen und therapeutischen Bereich der Hämatologie und Onkologie kompakt zu vermitteln, wird der Onko 3-Länder-Update Spezial vom 28. - 29. Juni 2019 in München durchgeführt. Dabei informieren ausgewiesene Experten aus Deutschland, Österreich und der Schweiz über die aktuellen Trends der (inter)nationalen klinischen Hämatologie/Onkologie-Therapie und -Forschung. Neben den wichtigsten chemo- und immun-therapeutischen Behandlungen von zahlreichen Organ- und Blutkrebsarten werden im Besonderen die Möglichkeiten und Herausforderungen innovativer diagnostischer Methoden fokussiert und im Plenum diskutiert.

Forum für medizinische Fortbildung;     Email: info@fomf.de

Onkologie/Hämatologie I, Onkologie/Hämatologie II, Onkologie/Hämatologie III, Onkologie/Hämatologie IV

Continuing Medical Education (CME),    Hematology

The 7th International Conference on Advances in Hematology and Oncology (#ICAHO19) is the premier Hematology/Oncology conference organized by the Binaytara Foundation in the Pacific Northwest. This year, ICAHO will be held in Seattle, Washington at the Crowne Plaza Downtown on June 29-30, 2019. It is designed to update healthcare professionals on the latest research and guidelines in the field. Like previous years, ICAHO19 will feature renowned faculties who will discuss about recent updates in Hematology and Oncology including a review of the 2019 ASCO® Annual Meeting.

Phone: [3607077593];     Email: jessie.d@binayfoundation.org

cancer, oncology, hematology, asco

Molecular Biology,    Genomics and Bioinformatics

We are pleased to invite you to the “2nd International Conference on Oncology and Hematology” on theme “Evolving Cancer Care and insight on Hematology” scheduled to be held at Brussels, Belgium during July 4-6, 2019 on behalf of Endling conferences. We would like to request you to collaborate with us and attain the mutual benefits. Also it is an honour and privilege to have your participation in this Conference as Speakers/Delegates/Exhibitors/conduct workshops

Phone: [1-702-602-4030];     Email: cancer@endlingconferences.com

Oncology, Cancer, Cancer therapy, Blood disorders, Hematology, Cancer Care

Themenschwerpunkte: Gastrointestinale Onkologie, Mikrobiom, Endoskopie, Personalisierte Medizin

Phone: [+49 3643 2468-145];     Email: lisa.dinter@kukm.de

Innere Medizin, Gastroenterologie

Our well respected annual masterclass for clinical nurse specialists and other senior nursing colleagues working in the field of haemato-oncology will take place in Oxford on Sunday 14 July. The course will provide a unique insight into the treatment and management of lymphomas and is a great opportunity to network and share best practice with other haemato-oncology nurse specialists.

Lymphoma Action;     Phone: [01296619412];     Email: conferences@lymphoma-action.org.uk

lymphoma, CLL, clinical nurse specialist, masterclass, clinical, nurse, specialist, co-morbidities, self management, living with lymphoma, living beyond lymphoma, gilly howard jones, lianne palmer, lymphoma action, rituximab, venetoclax, MURANO trial, haemato-oncology

The sixth annual Lymphoma Management course is returning to Keble College Oxford, Monday 15 - Tuesday 16 July 2019. Our expert faculty of lymphoma specialists from across the UK will provide a comprehensive overview of the diagnosis, treatment and management of lymphomas. This course is aimed at specialist trainees wishing to gain a deeper understanding of lymphoma or consultants who would like to refresh their knowledge. Completion of the course should equip participants in the following areas: 1. The principles underpinning diagnostic and therapeutic modalities as applied to lymphoma in all its subtypes. 2. An understanding of practical considerations when prescribing immunochemotherapy and radiotherapy. 3. To apply the most appropriate diagnostic techniques and therapeutic interventions to individual patients with a lymphoma diagnosis. 4. A thorough training in material which may be covered in professional exams e.g. FRCPath

Lymphoma Action;     Phone: [01296619412];     Email: conferences@lymphoma-action.org.uk

haematology, haematologist, oncology, oncologist, cancer, lymphoma, blood, lymphatic, lymphocyte, hodgkin, non hodgkin, high grade, low grade, follicular, b cell, t cell, mantle cell, wm, diagnostic, diagnostics, therapeutics, lymsym, symposium, lymphoma action, oxford, churchill, graham collins, toby eyre, charity, bsh, rcpath, cpd, cme

Medicalconferences invites all the attendees from all over the world to attend An international Conference on "Cancer Science & Stem cell Research ” This conference will assemble recentresearches & findings, oral talks, poster presentation ,Exhibition & other issues in Cancer science from July 03 - 05th, 2019 in Diamond city Amsterdam , Netherlands.

Phone: [+31728080590];     Email: cancerscience@medicalconferences.nl

Cancer conferences, Oncology Meetings, Stem Cell Research conference

Stem-cell Research & Therapy,    Molecular Biology

Epigenetics Conference, The world's largest Epigenetics Conference and Gathering for the Research Community.Join the 5th International Congress on Epigenetics & Chromatin at Vienna, Austria during August 22-23, 2019. Epigenetics 2019 invites all the participants on behalf of organizing committee from all over the world to attend "5th International Congress on Epigenetics & Chromatin " which includes prompt keynote presentations, oral seminars, poster presentations and exhibitions.

Phone: [+448000148923];     Email: epigeneticsconferences@gmail.com

Epigenetics: Global leading changes to advance Diagnosis & Precision medicine, Cancer, Cardio, Reproductive, Diabetes, Surgery, Neuroscience, Healthcare, Pathology, Radiology

Genomics and Bioinformatics,    Pharmacogenomics, Personalized medicine

The Indian Society of Haematology & Blood Transfusion (ISHBT), European Hematology Association (EHA) and Eastern Haematology Group (EHG) will jointly host the 1st Highlights of Past EHA (HOPE) in Asia from 23rd August to 25th August, 2019 in Kolkata. It is with great pleasure that we invite you to participate in this event. The event will be held at The Cultural Capital Of India , Kolkata.

Phone: [7488658371];     Email: hopekolkata2019@gmail.com

Bone Marrow Transplantation Transfusion Medicine Bone Marrow Failure RBC Diseases Platelet Disorders Coagulation Disorders Leukemia Multiple Myeloma Lymphoma Others

Congrex Switzerland Ltd.

The 51st Congress of The International Society of Paediatric Oncology will be held in Lyon, France, October 23-26, 2019. Join the Global Community striving towards a world free of childhood cancer!

Society of Hematologic Oncology

The ECCO 2019 European Cancer Summit on 12-14 September 2019 in Brussels, Belgium will bring together worldwide leaders from cancer care, research, patient advocacy and public-private sectors in a unique multi-stakeholder forum. The theme of the second edition of the ECCO Summit is: “European Cancer Care: Across Borders”. Reaching the 70:35 Vision for cancer – 70% long term survival for all cancer patients across Europe by 2035 – requires breaking down the borders of cancer care: between countries, professions, sectors and stakeholders.

ECCO Secretariat;     Phone: [+32 2 775 02 01];     Email: ecco@eccosummit.eu

oncology, cancer, policy, quality cancer care, cancer treatment, cancer research, cancer care, hpv, artificial intelligence

Nanotechnology offers exciting opportunities in the fight against cancer. New technological breakthroughs have enabled innovative therapeutic applications of nanoparticles and have facilitated diagnostics at the nanoscale. As examples, the delivery of RNA with nanoparticles (in the product patisiran), has been approved by EMA/FDA in 2018, while the first liquid biopsy for prostate cancer based on exosome analysis was launched in 2016.

Roger Doxat-Pratt;     Email: roger.doxat-pratt@eacr.org

cancer, nanotechnology, research, oncology, RNA, nanoparticles, nanoscale, therapeutic, treatment, nanomedicine, siRNA, mRNA, CRISPR-Cas9, exosomes, theranostics, immunotherapy

It is our pleasure to invite all of the great scientists, academicians, researchers, delegates and students from all over the world to attend the Euro Cancer Research Conference 2019 Rome, Italy. These three days conference was designed for sharing of latest information and ideas for research on cancer with other professors, researchers, delegates and students from all universities. This conference covers global aspects on cancer research and therapy.

Phone: [14693420402];     Email: cancerconferences1@gmail.com

Worldwide Bioleagues organize global cancer conferences to bring new innovations by updating latest research in various topics. On completing our first series on Oncology, now we are organizing our next series “2nd Indo-Oncology Summit-19”. The dates of Oncology Conference are September 13th&14th, 2019at Eastern India, Bhubaneswar.

Phone: [7358737843];     Email: yazhini@technoarete.org

International Academy for Clinical Hematology (IACH)

We are delighted to invite you to participate in the 2nd Annual Meeting of the International Academy for Clinical Hematology (IACH), taking place September 19-21, 2019 in Paris, France. The annual meeting of the IACH aims to create a comprehensive intellectual and operational environment for acquisition of knowledge, skills, clinical judgement, and attitudes essential for the practice of clinical hematology.

Email: moran@cme-congresses.com

Hematology Immune System

Hematology,    Stem-cell Research & Therapy

Hilaris Conference invite you to be a part of the Oncology conference in Paris, France on September 26-27, 2019 to discuss on the new innovations within the field of Oncology for providing a much better moreover as a healthier life for the individuals from exceptionally prominent people and display of Standard universities. Hilaris Conference on Oncology 2019 pleased to be able to invite those of you ready to share their knowledge towards Oncology as well as those who are knowledge gaining aspirants in a single stage.

Phone: [+359-825-18874];     Email: oncologymeet@gmail.com

The theme of the conference is entitled “Interventional Therapy in Modern Oncology: Technological Integration Beyond Boundaries”. There will be over 100 world renowned international faculties and 50 national speakers from regionally renowned institutions, sharing their skills, knowledge and insight into case management and presenting the latest developments in the oncological fields. Live case transmission is among the highlight of the event. With the aim of Technological Integration in Oncology Beyond Boundaries, our delegates can expect to take away from this congress knowledge on new and effective treatment technologies in various new interventional options. Our goal is to give delegates information that they can take back and apply in their practice and optimize the treatment choices they can offer to patients. We invite our colleagues to share their work and research through free paper oral presentations and live e poster presentation sessions. Call for abstracts will open soon.

APCIO 2019 Secretariat;     Phone: [+603 2276 0555];     Email: secretariat@apcio2019.com

This year we hope to continue to provide an update on what is new, challenging and controversial in the management of patients with breast cancer. We will address the developing new frontiers of the management of brain metastases in Breast cancer, as well as the role of immunotherapy.

Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

The European Congress on Clinical Oncology (ECCO) will be held on Saturday October 5, 2019 in Frankfurt Germany. The congress will encompass all topics within the field of clinical oncology.

Phone: [+41 43 5082905];     Email: office@spg.ltd

Challenges in immunotherapy treatment NSSLC: Improving outcomes in advances stages New options for managing breast cancer Early cancer diagnosis biomarkers Rethinking clinical trial design

We invite you to join us at the 2nd joint EACR-MRS Conference on Seed and Soil: Mechanisms of Metastasis. This is a joint conference organised by the European Association for Cancer Research (EACR) and Metastasis Research Society (MRS).

Metastasis formation is responsible for over 90% of cancer patient deaths, largely due to the fact that therapies are generally ineffective against detectable metastatic tumors. There is thus a crucial need to mechanistically understand the cellular, tissue and whole-body processes driving metastasis formation in order to identify effective therapeutic strategies. This conference will give an in-depth overview of our current knowledge on cancer, stromal and immune cell centred mechanisms promoting metastasis formation presented by world-leading researchers in the field.

Phone: [0115 951 5065];     Email: l.strachan@nottingham.ac.uk

cancer, tumor, tumour, metastasis, therapeutic, stromal, immune, cell, research, therapy, treatment, oncology

Oxford Global are proud to present the 2nd Annual Advances in Immuno-Oncology USA Congress, 8 - 9 October 2019, San Diego, USA. Join over 200 delegates from global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions. Over 40 presentations, case studies and panel discussions focusing on the latest innovations in Immuno-Oncology therapy development, patient stratification and clinical tools and research.

Phone: [+44 (0)1865 248455];     Email: a.saez@oxfordglobal.co.uk

Immuno-Oncology, CAR T-Cell Therapy, Clinical Oncology, Immunotherapy, Oncology Biomarkers

It is great pleasure that we invite you to participate in this very exciting conference on Kidney and Prostate cancer. Both are diverse diseases ranging from small clinically insignificant tumours to advance incurable malignancy.

Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

Urology, Andrology,    Nephrology

Preponderant experimental and clinical evidence has demonstrated that pervasive cancer cell heterogeneity in both phenotypic presentations and functional properties exists, such that a population of cancer cells with cardinal stem cell properties (i.e., cancer stem cells) pre-exists in untreated tumors and spatiotemporally evolves during tumor progression and therapeutic interventions. Recent studies have also revealed significant phenotypic and functional plasticity in cancer cells, regulated by both genetic networks and epigenetic mechanisms. Both cancer cell heterogeneity and plasticity constitute major barriers to efficient and durable clinical treatments. Ever since the revival of the cancer stem cell research field around the turn of the century, we have made great strides in identifying and elucidating the biology of cancer stem cells in virtually all tumor systems. Significant progress has also been made in understanding how cancer stem cells interact with the cellular constituents and soluble factors in the proinflammatory and immune-suppressive tumor microenvironment. Facilitated by an explosion of technical advances in recent years, especially single-cell RNA-seq, we are achieving an unprecedented appreciation of the complexity of the cellular heterogeneity of human tumors. Significantly, novel therapeutic strategies that target cancer stem cells and cancer cell heterogeneity and plasticity are rapidly progressing to the clinical arena. This conference is organized to recapitulate these recent advances in our understanding of cancer stem cell biology and, importantly, the clinical translation of targeting cancer stem cells.

Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org

stem cells, cancer, regenerative medicine, development

Stem-cell Research & Therapy,    Biology

This conference will focus on new clinical outcomes data, innovative treatment delivery and management approaches, and the latest advances in proton therapy.

Phone: [786-596-2398];     Email: juliez@baptisthealth.net

Proton Therapy conference; Radiation Oncology Conference; Oncology CME; Proton Therapy CME

The 8th Conference of IAOC "Current Status and Future of Anti-Cancer Therapies" will be held in Buenos Aires, Argentina in October 17th and 18th, 2019. An outstanding faculty of speakers from the United States and Europe has committed in this meeting. The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development. The major emphasis will be on clinical aspects of cancer treatment in the 21st century with discussion of significant scientific advances underlying the novel approaches still in preclinical development.

This meeting is the primary opportunity for oncologists, hematologists and cancer related health workers to participate in a conference focusing on novel targeted therapies and other treatment advances which are changing the face of cancer care.

Secretariat;     Email: secretariat@oncologyconferences.com.ar

NEW ANTICANCER THERAPIES, MELANOMA, BREAST CANCER, GU CANCER, PROSTATE AND RENAL CANCER, BLADDER CANCER, GI CANCER, LUNG CANCER, HEMATOLOGICAL MALIGNANCIES, LYMPHOMA, LEUKEMIA, MULTIPLE MYELOMA

United Scientific Group (A Non-Profit Organization) hosted three events still now on Cancer Research and Targeted Therapy twice in USA and once in UK. Having a total of 200 participants and their positive notes we are happy to announce our next event the fourth edition of Cancer Research & Drug Development at the largest independent city Baltimore USA this October 21-23, 2019.

Phone: [+1-408-426-4832];     Email: cancer.therapy@uniscigroup.org

Cancer Metastasis, Cancer Resistance, Cancer Microenvironment, Novel Therapeutics target in Cancer, Cancer drug development, Cancer Immunotherapy, Cancer Targeted Therapy, Cancer Nanomedicine, Cancer Radiation Therapy, Cancer Genetics, Breast Cancer, Uterine Cancer, Lung Cancer, Hematological Cancer, Sarcoma.

Since the inaugural Congress in 2001, this meeting has become the premier forum for discussion on the latest advances in myeloproliferative neoplasms (MPNs). This year, the Congress will focus on timely topics of interest to hematologists and oncologists who treat patients with these rare disorders. The Congress program format will utilize case presentations to highlight the essential features of MPN pathophysiology, diagnosis and management, as well as the roles of next generation sequencing and the MPN driver mutation and allele burden in clinical decision making. In addition to defining the role of pegylated interferon and its long-acting derivatives in MPN therapy, the role of immunotherapy in the MPNs and novel agents for MPN treatment will be reviewed. New this year will be a discussion of the management of accelerated and blast phase MPN, patient selection for bone marrow transplantation, and how to integrate MPN patient symptom scores with therapeutic planning. The program features a world class faculty and highly interactive sessions designed to engage participants and provide a state-of-the-art learning experience.

Phone: [512-619-5534];     Email: info@meltonmeded.com

myeloproliferative neoplasms, MPN, polycythemia vera, PV, essential thrombocythemia, ET, myelofibrosis, MF, PMF, Chronic myeloid leukemia, CML, CNL, mastocytosis, hematopoiesis

Hematology,    Continuing Medical Education (CME)

Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer

MAP 2019 - Molecular Analysis for Personalised Therapy is a unique meeting established by global opinion leaders. The congress aims to integrate insights from tumour sample analysis into daily practice. The MAP Congress has grown into an influential, highly interactive forum which is a natural choice for specialists working in precision medicine in oncology. The Congress programme is based on the genomic information obtained through the sequencing of all tumours and the tumour environment.

Phone: [+41 91 97 31 947];     Email: meetings@esmo.org

oncology, personalised medicine, precision medicine, genome alterations, genome sequencing, molecular analysis

Pharmacogenomics, Personalized medicine,    Translational Medicine, Clinical Trials

After the success of the last ten years, it is with great pleasure that you are invited to participate in the eleventh Royal Marsden Head and Neck Conference. The meeting will be of particular interest to maxilliofacial, ENT or plastic surgeons with an interest in head and neck oncology, as well as clinical/medical oncologists, radiologists and pathologists.

Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

Palliative Surgey, pre-frailty and frailty, biology of the ageing cell, end of life care,

Der Hämato/Onko Refresher findet vom 08. - 09. November 2019 in Berlin statt. In kurzen, 30 – 45 minütigen Vorträgen werden die neuesten diagnostischen und therapeutischen Leitlinien der Hämatologie und Onkologie von Spezialisten präsentiert und auf Ihre Fragen eingegangen. Dabei wird vor allem auf Praxisrelevanz großen Wert gelegt.

Forum für medizinische Fortbildung;     Phone: [+49 (0) 6192 957 89 41];     Email: info@fomf.de

Hämatologie, Onkologie

Hematology,    Continuing Medical Education (CME)

The 4th edition of this highly successful conference will focus on the latest advances in 3D-based cellular models and emerging topics in the areas of cell architecture, mechanobiology, the immune microenvironment, high level imaging and high-content analysis for cancer therapeutics. The conference format is designed to encourage networking in order to develop approaches that translate to outcomes.

Phone: [0115 951 5065];     Email: roger.doxat-pratt@nottingham.ac.uk

cancer, oncology, research, cell adhesion, migration, mechanics, tumour invasion, 3D, in vitro, drug development, multicellular, immune, microenvironment, culture, mechanobiology

This event will provide an overview of cancer immunotherapy, with a focus on the recognition and management of immune-mediated toxicities. The meeting will have a strong clinical emphasis, aimed at providing delegates with practical guidance that can be utilised in daily practice.

Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

ABC has established itself as a major international breast cancer conference. Its primary aim is the development of international consensus guidelines for the management of advanced breast cancer patients. These treatment guidelines are based on the most up-to-date evidence and can be used and adapted to many different health care settings globally.

Phone: [+39 02 8546451];     Email: communication@eso.net

Breast cancer, Adcanced breast cancer, Metastatic breast cancer

Der Hämato/Onko Refresher findet vom 15. - 16. November 2019 in Stuttgart statt. In kurzen, 30 – 45 minütigen Vorträge werden die neuesten diagnostischen und therapeutischen Leitlinien der Hämatologie und Onkologie von Spezialisten präsentiert und auf Ihre Fragen eingegangen. Dabei wird vor allem auf Praxisrelevanz großen Wert gelegt.

Forum für medizinische Fortbildung;     Phone: [+49 (0) 6192 957 89 41];     Email: info@fomf.de

Hämatologie, Onkologie

Hematology,    Continuing Medical Education (CME)

The Sixth Royal Marsden lung cancer symposium will tackle burning issues and key challenges facing clinicians treating patients with lung cancer. We have assembled a combination of highly knowledgeable faculty members who will be talking on topics including, lung cancer screening, biomarker testing, systemic and local therapies in both NSCLC and SCLC.

Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

Der Hämato/Onko Refresher findet vom 29. - 30. November 2019 in Köln statt. In kurzen, 30 – 45 minütigen Vorträgen werden die neuesten diagnostischen und therapeutischen Leitlinien der Hämatologie und Onkologie von Spezialisten präsentiert und auf Ihre Fragen eingegangen. Dabei wird vor allem auf Praxisrelevanz großen Wert gelegt.

Forum für medizinische Fortbildung;     Phone: [+49 (0) 6192 957 89 41];     Email: info@fomf.de

Hämatologie, Onkologie

Hematology,    Continuing Medical Education (CME)

ESMO’s Sarcoma & GIST Symposium is a highly specialised meeting bringing together the most brilliant medical minds working on these tumour types. The Symposium is known as the place of choice for international networking and collaboration, featuring discussions with the key opinion leaders in these rare sub-entities.The Symposium brings translational researchers and clinicians together and builds on an integrated approach for improved patient outcomes.

Phone: [+41 91 97 31 939];     Email: registration@esmo.org

sarcoma, gist, gastrointestinal stromal tumours, rare cancers, translational research, oncology, cancer, soft tissue sarcomas, medical oncology, surgical oncology, radiotherapy, pathology

Evading programmed cell death is a major hallmark of cancer cells and contributes to tumor progression and therapy resistance. Emerging hallmarks such as metabolic plasticity, genomic instability and an immunosuppressive tumor environment allow the tumors to escape from standard cytotoxic as well as targeted therapies. Thus, understanding the underlying mechanisms in appropriate pre-clinical/clinical models is crucial for the design of more effective combination therapies to avoid treatment failure or tumor recurrence. The EACR Special Conference “A Matter of Life or Death: Mechanisms, Models and Therapeutic Opportunities” is the 5th Conference on this topic. Its objective is to cover recent and exciting developments in the field of cancer research that are crucial to our understanding of the multifaceted role of cell death in tumor initiation, progression and therapy response.

The 4th DNA Repair/Replication Structures & Cancer conference in February 2020 will focus on structural and mechanistic insights into dynamic protein, chromatin, DNA and RNA complexes acting in DNA repair and its interface with DNA replication and transcription events relevant to cancer. This fundamental information will be pivotal for the accurate interpretation of cancer clinical data, design of clinical trials, prognosis, etiology and improving the currently 1/20 low success rate for oncology drug clinical trials. Informative talks and poster sessions along with vibrant discussions will foster productive interactions and collaborations.

Conference Manager;     Phone: [+441638724137];     Email: admin@fusion-conferences.com

DNA, DNA Repair, DNA replication, RNA, Cancer, DNA damage signaling, cross-talk, Epigenetics, PARP, PARG, metabolic signalling, Mitochondrial replication, apoptosis

Molecular Biology,    Biology

Der DKK 2020 steht unter dem Motto informativ. innovativ. integrativ. Optimale Versorgung für alle.

Phone: [+49 3643 2468-0];     Email: info@kukm.de

Knowing how cells respond to DNA damage is critical to our understanding of tumourigenesis, genomic instability, and the cellular response to DNA-damaging chemotherapy and radiotherapy. DNA damage responses take place in the context of chromatin and in the midst of ongoing transcription and replication. Moreover, the metabolic environment, which is altered in tumour cells, influences these activities. In this conference, we aim to bring together researchers working on understanding DNA damage responses in the context of complex and dynamic cellular environments. This is an exciting and fast moving area, and this conference features an excellent international line-up of speakers. The programme will address the challenges of understanding this complex field and will emphases new experimental approaches for interrogating these pathways. We will also consider how recent advances can be exploited in the clinic.

DNA damage responses, cancer, oncology, Epigenetic, radiotherapy, transcription, immune, repair, tumourigenesis, cellular, genomic

Phone: [+4936413116390];     Email: conferencemarketing@conventus.de

Phone: [+4936413116390];     Email: conferencemarketing@conventus.de

Phone: [+4936413116390];     Email: julia.wrenczycki@conventus.de